All products

Zetasizer Core

Malvern Panalytical

Zetasizer Core measures DLS, SLS and DSF on a standard well plate, showing biologics teams not just whether a candidate is unstable, but the mechanisms driving it.
Manufacturer Malvern Panalytical
Product Series Malvern Zetasizer
Measurement principle Dynamic Light Scattering (DLS), Static Light Scattering (SLS), Differential Scanning Fluorimetry (DSF)
Application Nano Particle Size, Molecular weight, Aggregation, Colloidal stability, Thermal unfolding, Ligand binding and Chemical denaturation.
Measurement throughput 192 samples per minute (DSF/SLS)
Size range 0.6 nm – 2000nm (diameter)
Sample volume 4 μL (1536 well plate); 10 uL (384 round well plate); 100 uL (96 well plate)
Minimum sample concentration 0.125 mg/mL, 14 kDa

The Zetasizer Core from Malvern Panalytical brings dynamic light scattering (DLS), static light scattering (SLS) and differential scanning fluorimetry (DSF) together in a high-throughput, plate-based system designed for biologics formulation and stability screening.

By combining measurements of particle size, protein–protein interactions and thermal stability, Zetasizer Core helps researchers understand not only whether a formulation is stable, but what may be driving its behaviour.

The Zetasizer Core combines 3 measurements into one simple workflow.

  • DLS: Measure hydrodynamic size and polydispersity to identify changes in particle size and aggregation.
  • SLS: Measure protein–protein interactions, including the second virial coefficient (B22), to understand molecular interactions that can influence formulation stability.
  • DSF: Measure thermal stability and unfolding behaviour to assess the structural stability of your protein.

Together, DLS, SLS and DSF provide a more complete picture of formulation stability, helping identify promising candidates for further development. Combining these techniques in one system eliminates the need for sample transfer and separate sample preparation between different instruments.  This reduces ambiguity between measurements performed at different times or under different conditions helping to distinguish genuine formulation instability from changes introduced by the measurement environment.

Compatible with standard 96-, 384- and 1536-well plates, the Zetasizer Core requires no proprietary consumables and connects directly with existing plate handling robotics, liquid handlers and laboratory information management systems (LIMS). With volumes as low as 4 µL and throughput of up to 192 samples per experiment at 1°C/min thermal ramp, researchers can rapidly screen formulation conditions including pH, buffer composition, excipients, surfactants and concentration in a single workflow.

The system uses the same DLS algorithms and adaptive correlation technology as the Zetasizer Advance range, helping reduce revalidation when moving from discovery to quality control. Automation-ready capabilities support integration with standard laboratory robotics through an open API and barcode reader (coming soon). OmniTrust for 21 CFR Part 11 compliance (coming soon) will further support secure, traceable and compliant high-throughput workflows.

Resources

High-throughput screening — measure up to 192 samples per minute

Low sample volumes — as little as 4 µL in 1536-well format

Three complementary techniques — DLS, SLS and DSF in one system

Multidimensional stability data — assess size, molecular interactions and thermal stability

Standard microplates — compatible with 96-, 384- and 1536-well formats

Automation-ready — designed to integrate with high-throughput laboratory workflows

Conserve valuable samples — screen more conditions using less protein

Zetasizer Core is suited to applications where formulation stability, aggregation and protein interactions need to be investigated across large numbers of conditions.

Monoclonal antibodies
Screen formulation conditions and investigate aggregation and stability behaviour.

Recombinant proteins
Compare buffer, pH, excipient and concentration effects while conserving valuable material.

Vaccines and complex biologics
Investigate formulation-dependent changes in size, interactions and thermal stability.

Protein therapeutics
Accelerate early formulation screening and identify candidates for further development.

Biopharmaceutical discovery and development
Generate complementary stability information before committing resources to more detailed characterisation.

Explore

Similar products

Interested in learning more about this system?

Get in touch for a free consultation